Skip to main content

Table 4 Clinical characteristics of the validation cohort

From: Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis

  Sarcoidosis Other ILDs
Number of patients 8 45
Number of lymphocytes analyzed 439 2662
Age 56.3 ± 5.0 65.0 ± 2.0
Gender (male/female) 3/5 25/20
Smkoking (yes/no) 4/4 23/21 (NR: 1)
 IIPs (COP or AIP)   5
 IIPs (uILD)   5
 CTD-ILD   12
 HP   4
 DILD   11
 Infection   2
 Others   6
  1. ILD, interstitial lung disease; NR, not reported; IIP, idiopathic interstitial pneumonia; COP, cryptogenic organizing pneumonia; AIP, acute interstitial pneumonia; uILD, unclassifiable interstitial lung disease; CTD-ILD, connective tissue disease-associated interstitial lung disease; HP, hypersensitivity pneumonia; DILD, drug-induced interstitial lung disease